Amyotrophic lateral sclerosis (ALS) is the most common adult-onset motor neuron disease.
ALS is a progressive neurodegenerative disorder, involving motor neurons in the cerebral …

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease primarily affecting the
upper and lower motor neurons. The lifetime risk of developing ALS is estimated at 1: 350 for …

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that results in
progressive loss of bulbar and limb function. Patients typically die from respiratory failure …

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that
selectively affects the motor neurons of the brain and spinal cord. ALS occurs in about 1 in …

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease associated
with a life expectancy of approximately 3 years after symptom onset, but the range of survival …

Amyotrophic lateral sclerosis (ALS), identified as a distinct clinical entity by Charcot since the
end of the nineteenth century, is a devastating and fatal neurodegenerative disorder that …

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterised by
progressive muscular paralysis reflecting degeneration of motor neurones in the primary …

Amyotrophic lateral sclerosis (ALS) is a clinically progressive neurodegenerative syndrome
predominantly affecting motor neurons and their associated tracts. Riluzole and edaravone …

Adult motor neuron disease (amyotrophic lateral sclerosis [Als]) is a neurodegenerative
disorder characterized by loss of motor neurons in the cortex, brain stem, and spinal cord …

Amyotrophic lateral sclerosis (ALS), although a disease that has been well recognized for
nearly 150 years, still causes problems of diagnosis and management, as there is no …